Russell Investments Group, Ltd. Agenus Inc Transaction History

Russell Investments Group, Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$1.3 - $2.64 $31,200 - $63,360	24,000 New	24,000 $46,000
Q3 2021 Nov 08, 2021	SELL	$4.98 - $6.63 $39,018 - $51,946	-7,835 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$2.56 - $5.49 $869,980 - $1.87 Million	-339,836 Reduced 97.75%	7,835 $43,000
Q1 2021 May 10, 2021	SELL	$2.69 - $5.25 $117,679 - $229,671	-43,747 Reduced 11.18%	347,671 $944,000
Q4 2020 Feb 08, 2021	BUY	$3.17 - $4.49 $779,731 - $1.1 Million	245,972 Added 169.12%	391,418 $1.25 Million
Q3 2020 Nov 09, 2020	SELL	$2.98 - $5.2 $4,627 - $8,075	-1,553 Reduced 1.06%	145,446 $582,000
Q2 2020 Aug 05, 2020	BUY	$2.29 - $4.24 $11,349 - $21,013	4,956 Added 3.49%	146,999 $577,000
Q1 2020 May 06, 2020	BUY	$1.92 - $4.39 $272,722 - $623,568	142,043 New	142,043 $346,000
Q3 2018 Oct 26, 2018	SELL	$1.59 - $2.42 $66,380 - $101,032	-41,749 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$3.51 - $6.04 $146,538 - $252,163	41,749 New	41,749 $197,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.